http://opendata.unex.es/recurso/educacion/universidad/personal/32b66e6faa99cdafcc2c52744555cbb1-guillermo-gervasini-rodriguez
Relations
- teach:teacherOf
- ou:tienePublicacion
- A 3′-UTR polymorphism in soluble epoxide hydrolase gene is associated with acute rejection in renal transplant recipients
- A common polymorphism in the bile acid receptor farnesoid X receptor is associated with decreased hepatic target gene expression
- A custom target next-generation sequencing 70-gene panel and replication study to identify genetic markers of diabetic kidney disease
- A neutron diagnostic for high current deuterium beams.
- ABCB1 polymorphisms are associated with cyclosporine-induced nephrotoxicity and gingival hyperplasia in renal transplant recipients
- Adinosine triphosphate-binding cassette B1 (ABCB1) (multidrug resistance 1) G2677T/A gene polymorphism is associated with high risk of lung cancer
- Applicability of an Assay for Routine Monitoring of Highly Variable Concentrations of Olanzapine Based on HPLC with Mass Spectrometric Detection
- Association of COMT val158met polymorphism with psychopathological symptoms in patients with eating disorders
- Association of polymorphisms in leptin and adiponectin genes with long-term outcomes in renal transplant recipients
- BDNF genetic variability modulates psychopathological symptoms in patients with eating disorders
- Body Fat Distribution, Adipocytokines Levels and Variability in Associated Genes and Kidney Transplant Outcomes
- CYP1A1 gene polymorphisms increase lung cancer risk in a high-incidence region of Spain: A case control study
- CYP2C83 polymorphism and donor age are associated with allograft dysfunction in kidney transplant recipients treated with calcineurin inhibitors
- CYP2W1 variant alleles in Caucasians and association of the CYP2W1 G541A (Ala181Thr) polymorphism with increased colorectal cancer risk
- CYP3A genotypes of donors but not those of the patients increase the risk of acute rejection in renal transplant recipients on calcineurin inhibitors: a pilot study
- Central nervous system chemotoxicity during treatment of pediatric acute lymphoblastic leukemia/lymphoma
- Clinical implications of methotrexate pharmacogenetics in childhood acute lymphoblastic leukaemia
- Clinical relevance of erythrocyte ferritin in microcytic anemias
- Combined donor-recipient genotypes of leptin receptor and adiponectin gene polymorphisms affect the incidence of complications after renal transplantation
- Comparative cytochrome p450 in vitro inhibition by atypical antipsychotic drugs.
- Contaminants in Dietary Supplements: Toxicity, Doping Risk, and Current Regulation
- Diagnostic and therapeutic challenges of primary autoimmune haemolytic anaemia in children
- Diagnostic utility of HFE variants in Spanish patients: Association with HLA alleles and role in susceptibility to acute lymphoblastic leukemia
- Differences in CYP3A5*3 genotype distribution and combinations with other polymorphisms between Spaniards and other Caucasian populations
- Different distribution of the common HFE variants between western and eastern Spanish populations evidences an independent haplotype gene flow
- Dihydrofolate reductase genetic polymorphisms affect methotrexate dose requirements in pediatric patients with acute lymphoblastic leukemia on maintenance therapy
- Discussing the putative role of obesity-associated genes in the etiopathogenesis of eating disorders
- Early detection of drug interactions utilizing a computerized drug prescription handling system - Focus on cerivastatin-gemfibrozil
- Effect of common NAT2 variant alleles in the acetylation of the major clonazepam metabolite, 7-aminoclonazepam.
- Effect of dopamine receptor D4 (DRD4) haplotypes on general psychopathology in patients with eating disorders
- Effect of neurotransmitters on NADPH-cytochrome P450 reductase in vitro activity.
- Effect of polymorphisms in transporter genes on dosing, efficacy and toxicity of maintenance therapy in children with acute lymphoblastic leukemia
- Ethylenediaminetetraacetic acid-dependent pseudomacrocytosis
- Etiopathological mechanisms and clinical characteristics of hyperhemolysis syndrome in Spanish patients with thalassemia
- Evaluation of a drug-drug interaction alert structure through the retrospective analysis of statins-macrolides co-prescriptions
- Functional consequences of transferrin receptor-2 mutations causing hereditary hemochromatosis type 3
- GST polymorphisms interact with dietary factors to modulate lung cancer risk: Study in a high-incidence area
- Genetic variability in CYP3A4 and CYP3A5 in primary liver, gastric and colorectal cancer patients
- Genetic variants in dopamine pathways affect personality dimensions displayed by patients with eating disorders
- Genetic variants in pge2 receptors modulate the risk of nephrosclerosis and clinical outcomes in these patients
- Genetics variants in the epoxygenase pathway of arachidonic metabolism are associated with eicosanoids levels and the risk of diabetic nephropathy
- Genotype-phenotype associations for common CYP3A4 and CYP3A5 variants in the basal and induced metabolism of midazolam in European- and African-American men and women
- Haplotypes in the 5′-untranslated region of the CYP1A2gene are inversely associated with lung cancer risk but do not correlate with caffeine metabolism
- Hyperhaemolysis syndrome responsive to splenectomy in a patient with δβ-thalassaemia: A discussion on underlying mechanisms
- Impact of NEGR1 genetic variability on psychological traits of patients with eating disorders
- Impact of genetic polymorphisms on chemotherapy toxicity in childhood acute lymphoblastic leukemia
- Impact of genetic polymorphisms on tacrolimus pharmacokinetics and the clinical outcome of renal transplantation
- In vivo evaluation of CYP2A6 and xanthine oxidase enzyme activities in the Serbian population
- Influence of TFAP2B and KCTD15 genetic variability on personality dimensions in anorexia and bulimia nervosa
- Influence of dopamine polymorphisms on the risk for anorexia nervosa and associated psychopathological features
- Influence of variability in the cyclooxygenase pathway on cardiovascular outcomes of nephrosclerosis patients
- Inhibition of cytochrome P450 2C9 activity in vitro by 5-hydroxytryptamine and adrenaline
- Melanocortin-4 receptor gene variants are not associated with binge-eating behavior in nonobese patients with eating disorders
- Methotrexate-induced subacute neurotoxicity in a child with acute lymphoblastic leukemia carrying genetic polymorphisms related to folate homeostasis
- Modulation of CYP1A2 enzyme activity by indoleamines: Inhibition by serotonin and tryptamine
- Modulation of midazolam 1-hydroxylation activity in vitro by neurotransmitters and precursors
- N-acetyltransferase-2 (NAT2) gene polymorphisms and enzyme activity in serbs: Unprecedented high prevalence of rapid acetylators in a white population
- Novel variants in the MC4R and LEPR genes among severely obese children from the iberian population
- Observation of the effects of dust particles on plasma fluctuation spectra.
- Pharmacogenetic testing and therapeutic drug monitoring are complementary tools for optimal individualization of drug therapy
- Pharmacogenetics and personalized medicine. Are expectations being met?
- Pharmacogenetics of cytochrome P450 (CYP) 1A2 and variability in psychotropic drug response
- Plasma and urinary concentrations of arachidonic acid-derived eicosanoids are associated with diabetic kidney disease
- Polymorphisms in ABCB1 and CYP19A1 genes affect anastrozole plasma concentrations and clinical outcomes in postmenopausal breast cancer patients
- Polymorphisms in CYP-mediated arachidonic acid routes affect the outcome of renal transplantation
- Polymorphisms in genes involved in vasoactive eicosanoid synthesis affect cardiovascular risk in renal transplant recipients
- Polymorphisms in glucose homeostasis genes are associated with cardiovascular and renal parameters in patients with diabetic nephropathy
- Polymorphisms in human organic anion-transporting polypeptide 1A2 (OATP1A2): Implications for altered drug disposition and central nervous system drug entry
- Polymorphisms in methotrexate pathways: What is clinically relevant, what is not, and what is promising
- Polymorphisms in serotonergic genes and psychopathological traits in eating disorders
- Polymorphisms in the SNRPN gene are associated with obesity susceptibility in a Spanish population
- Polymorphisms in vasoactive eicosanoid genes of kidney donors affect biopsy scores and clinical outcomes in renal transplantation
- Potential beneficial effects of sacubitril-valsartan in renal disease: a new field for a new drug
- Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: Modulation by endogenous compounds
- Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease
- Prognostic Significance of Amino Acid and Biogenic Amines Profiling in Chronic Kidney Disease
- Promoting appropriate drug use through the application of the Spanish drug-related problem classification system in the primary care setting
- Recent Advances and Remaining Challenges in the Management of Diabetic Kidney Disease
- Relevancia de los polimorfismos genéticos en la respuesta farmacológica
- Research update for articles published in EJCI in 2015
- Retinal toxic reactions following photopheresis
- Risk factors for post-transplant diabetes mellitus in renal transplant: Role of genetic variability in the CYP450-mediated arachidonic acid metabolism
- Role of Obesity and Mediators of Adipose Tissue in Renal Transplant and Disease
- Role of the smoking-induced cytochrome P450 (CYP)1A2 and polymorphic CYP2D6 in steady-state concentration of olanzapine
- Sacubitril-valsartan improves anemia of cardiorenal syndrome (Crs)
- Tag-SNPs in Phospholipase-Related Genes Modify the Susceptibility to Nephrosclerosis and its Associated Cardiovascular Risk
- Terapéutica y farmacología práctica veterinaria, 2010-2011
- Thalassemia diagnosis in a blood donor from a unique trimorphic red blood cell population observed in the recipient
- The effect of CYP2J2, CYP3A4, CYP3A5 and the MDR1 C3435T polymorphisms and gender on the urinary excretion of the metabolites of the H<inf>1</inf>-receptor antihistamine ebastine: A pilot study
- Thrombocytopenia and fatality associated with olanzapine [2]
- Thrombocytopenia and fatality associated with olanzapine.
- Toward a clinical practice guide in pharmacogenomics testing for functional polymorphisms of drug-metabolizing enzymes. Gene/drug pairs and barriers perceived in Spain
- Tryptamine: A possible endogenous substrate for CYP2D6
- Using a computerized drug prescription screening system to trace drug interactions in an outpatient setting
- Variability in cannabinoid receptor genes is associated with psychiatric comorbidities in anorexia nervosa
- Variability in the antioxidant MSRA gene affects the psychopathology of patients with anorexia nervosa
- Variability in the leptin receptor gene and other risk factors for post-transplant diabetes mellitus in renal transplant recipients
- Variability of the L-Histidine decarboxylase gene in allergic rhinitis
- Variants in the Obesity-Linked FTO gene locus modulates psychopathological features of patients with Anorexia Nervosa
- ou:perteneceAGrupoInvestigacion
- ou:imparteDocenciaEnArea
- ou:adscritoACentro
- ou:adscritoADepartamento
Inverse Relations
Inverse Blank Nodes
